A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Banno, Masahiro ^a   Koide, Takayoshi ^a   Aleksic, Branko ^a,b   Yamada, Kazuo ^c   Kikuchi, Tsutomu ^a,d   Kohmura, Kunihiro ^a   Adachi, Yasunori ^a   Kawano, Naoko ^a   Kushima, Itaru ^a   Ikeda, Masashi ^b   Inada, Toshiya ^e   Yoshikawa, Takeo ^c   Iwata, Nakao ^b   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d Matsuzaki Hospital   (Japan)

^e SEIWA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; COGNITION; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPILIN AND TOLLOID LIKE 1 GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WISCONSIN CARD SORTING TEST; ASIAN; GENETICS; LONG TERM POTENTIATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

MEMBRANE PROTEIN; NETO1 PROTEIN, HUMAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COGNITION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LONG-TERM POTENTIATION; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 83755173781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028929     Document Type: Article

References (36)

1. Steinpreis R, (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res 74: 45-55.
2. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH, (2007) NMDA receptors and schizophrenia. Current opinion in pharmacology 7: 48-55.
3. Stephan KE, Baldeweg T, Friston KJ, (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59: 929-939.
4. Belforte J, Zsiros V, Sklar E, Jiang Z, Yu G, et al. (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13: 76-83.
5. Stohr H, Berger C, Frohlich S, Weber BH, (2002) A novel gene encoding a putative transmembrane protein with two extracellular CUB domains and a low-density lipoprotein class A module: isolation of alternatively spliced isoforms in retina and brain. Gene 286: 223-231.
6. Li F, Tsien JZ, (2009) Memory and the NMDA receptors. N Engl J Med 361: 302-303.
7. Ng D, Pitcher GM, Szilard RK, Sertie A, Kanisek M, et al. (2009) Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning. PLoS Biol 7: e41.
8. Tang TT, Yang F, Chen BS, Lu Y, Ji Y, et al. (2009) Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Proc Natl Acad Sci U S A 106: 21395-21400.
9. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, et al. (2000) Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157: 1141-1149.
10. Straub C, Hunt DL, Yamasaki M, Kim KS, Watanabe M, et al. (2011) Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1. Nature neuroscience.
11. Copits BA, Robbins JS, Frausto S, Swanson GT, (2011) Synaptic Targeting and Functional Modulation of GluK1 Kainate Receptors by the Auxiliary Neuropilin and Tolloid-Like (NETO) Proteins. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 7334-7340.
12. O'Donnell L, Soileau B, Heard P, Carter E, Sebold C, et al. (2010) Genetic determinants of autism in individuals with deletions of 18q. Hum Genet 128: 155-164.
13. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, et al. (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65: 45-53.
14. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
15. Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, et al. (2011) Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 69: 472-478.
16. Shi G, Boerwinkle E, Morrison AC, Gu CC, Chakravarti A, et al. (2011) Mining gold dust under the genome wide significance level: a two-stage approach to analysis of GWAS. Genetic epidemiology 35: 111-118.
17. Yamada K, Iwayama Y, Hattori E, Iwamoto K, Toyota T, et al. (2011) Genome-wide association study of schizophrenia in Japanese population. PloS one 6: e20468.
18. Lin PI, Vance JM, Pericak-Vance MA, Martin ER, (2007) No gene is an island: the flip-flop phenomenon. American journal of human genetics 80: 531-538.
19. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
20. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
21. Anderson CA, Soranzo N, Zeggini E, Barrett JC, (2011) Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 9: e1000580.
22. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB, (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
23. Aleksic B, Kushima I, Ito Y, Nakamura Y, Ujike H, et al. (2010) Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population. Schizophrenia research 118: 113-117.
24. Barrett J, Fry B, Maller J, Daly M, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
25. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
26. Dudbridge F, (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human heredity 66: 87-98.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
28. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L, (1988) The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26: 223-238.
29. Heaton RK, (1981) The Wisconsin Card Sorting Test (Manual) Odessa, FL Psychological Assessment Resources.
30. Kashima H, Handa T, Kato M, Sakuma K, Yokoyama N, et al. (1987) Neuropsychological investigation on chronic schizophrenia. Aspects of its frontal functions. In: Takahashi R, Flor-Henry P, Gruzelier J, Niwa S, editors. Amsterdam Elsevier.
31. Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, et al. (2006) Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 86: 138-146.
32. Suzuki H, Gen K, Inoue Y, (2011) An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35: 161-168.
33. Heaton RK, Chelune GL, Talley JL, Kay GG, Curtiss G, (1993) Wisconsin Card Sorting Test manual: revised and expanded Oclessa, FL Psychological Assessment Resourses.
34. Inagaki A, Inada T, (2008) Dose equivalence of psychotropic drugs. pp. 887-890 Part XXI: dose equivalence of novel antipsychotics: Blonanserin. Rinsho Seishin Yakuri (Japanese Journal of Clinical Psychopharmacology).
35. Inagaki A, Inada T, (2010) Dose equivalence of psychotropic drugs. pp. 1349-1353 Part XXII: dose equivalence of depot antipsychotics III: risperidon long-acting injection. Rinsho Seishin Yakuri (Japanese Journal of Clinical Psychopharmacology).
36. Kay SR, Fiszbein A, Opler LA, (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.